← feed

Is NCT03368339 results overdue?

Yes — results are overdue. Primary completion was 2018-01-21; the FDAAA-801 reporting deadline (2019-01-21) passed 2708 days ago and no results are posted on ClinicalTrials.gov.

Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis

NCT IDNCT03368339 ↗
SponsorRealm Therapeutics, Inc. (INDUSTRY)
PhasePHASE2
StatusCOMPLETED
Primary completion2018-01-21 (ACTUAL)
Reporting deadline2019-01-21 (completion + 365d)
Days overdue2708
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 9e4b765e85193d7f… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03368339. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →